Thundas, Baby Boy .
HRN: 26-35-86 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/13/2024
AMPICILLIN 250MG (VIAL)
12/13/2024
12/20/2024
IV
175 Mg
Q12hrs
Neonatal Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes